Hui Tian
CEO
AI
Axbio Inc.
4/10Traction
Axbio develops a high-throughput Bio-CMOS platform for next-generation gene sequencing and molecular diagnostics, utilizing nanopore sequencing technology for real-time, single-molecule analysis. Their solutions address the need for rapid and accurate genomic data generation, enhancing diagnostic capabilities in healthcare and research.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Current gene sequencing and molecular diagnostic methods often lack the throughput and speed required for rapid analysis and real-time results, hindering timely decision-making in healthcare and research settings. Existing technologies may also be limited in their ability to perform single-molecule analysis, affecting accuracy and sensitivity.
Solution
Axbio is developing a Bio-CMOS platform that leverages nanopore sequencing technology for high-throughput gene sequencing and molecular diagnostics. Their platform enables real-time, single-molecule analysis, providing rapid and accurate genomic data. The core of the technology is a Bio-CMOS chip with a high density of nanopores, which facilitates high-throughput sequencing at a lower cost. Axbio's solutions aim to improve diagnostic capabilities and accelerate research by providing faster and more precise genomic information.
Target Audience
The primary target audience includes healthcare providers, research institutions, and diagnostic companies seeking advanced solutions for rapid and accurate gene sequencing and molecular diagnostics.
Features
- High-throughput sequencing using a Bio-CMOS platform
- Nanopore sequencing technology for real-time, single-molecule analysis
- Bio-CMOS chip with a high density of nanopores for increased throughput
- Technology uses a "nanopore sequencing by synthesis" approach, incorporating polymerase and labeled modified nucleotides for base identification and physical correction through single-molecule cyclic re-sequencing
- Electrochemical impedance detection technology for smaller, denser, more stable, and higher-throughput detection units compared to DC electrical signals
- Specializes in developing fourth-generation gene sequencing platforms, nucleic acid joint testing platforms, and corresponding reagent kit products